Other substances

SARS-CoV-2 saRNA LNP vaccine

Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Vaccine

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

 

Supporting references

Link Tested on Impact factor Notes Publication date
Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine induces equivalent preclinical antibody titers and viral neutralization to recovered COVID-19 patients
Preprint 		mice Apr/25/2020
Export (.csv)